Compare CTSO & TPCS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CTSO | TPCS |
|---|---|---|
| Founded | 1997 | 1956 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Metal Fabrications |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 45.7M | 40.9M |
| IPO Year | 2008 | 2008 |
| Metric | CTSO | TPCS |
|---|---|---|
| Price | $0.73 | $3.72 |
| Analyst Decision | Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $5.38 | N/A |
| AVG Volume (30 Days) | ★ 67.1K | 43.8K |
| Earning Date | 01-01-0001 | 05-25-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 64.20 |
| EPS | ★ N/A | N/A |
| Revenue | $22,503,908.00 | ★ $34,031,000.00 |
| Revenue This Year | $7.29 | N/A |
| Revenue Next Year | $8.91 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 48.53 | 7.72 |
| 52 Week Low | $0.60 | $2.08 |
| 52 Week High | $1.39 | $6.25 |
| Indicator | CTSO | TPCS |
|---|---|---|
| Relative Strength Index (RSI) | 54.78 | 32.85 |
| Support Level | $0.62 | $3.67 |
| Resistance Level | $0.84 | $3.85 |
| Average True Range (ATR) | 0.04 | 0.16 |
| MACD | 0.01 | 0.01 |
| Stochastic Oscillator | 59.46 | 46.94 |
CytoSorbents Corp specializes in treating life-threatening conditions in intensive care and cardiac surgery using proprietary polymer adsorption technology. Its flagship product, CytoSorb, is approved in the EU as an extracorporeal cytokine absorber, aiming to reduce inflammation and prevent multiple organ failure in critical illnesses like sepsis and trauma. Revenue primarily comes from product sales in Germany, with additional income from grant agencies in the United States. The company operates through Direct sales and Distributors/strategic partners in United States, Germany and Other Countries. The company's product consists of Cytosorb, ECOS-300CY, VetResQ, HemoDefend, and DrugSorb-ATR.
Techprecision Corp manufactures metal fabricated and machined precision components and systems. It offers a full range of services required to transform raw materials into precision finished products. The company's products are used in markets including defense, aerospace, nuclear, medical, and precision industries. All of its operations and customers are located in the United States. The company have two wholly owned subsidiaries that are each reportable segments: Ranor and Stadco. Each reportable segment focuses on the manufacture and assembly of specific components. It derives maximum revenue from Ranor segment.